Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

ConditionsTakayasu Arteritis With Pulmonary Artery Involvement Percutaneous Transluminal Pulmonary Angioplasty PAH Targeted Medication

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorChinese Pulmonary Vascular Disease Research Group

About this trial

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Eligibility criteria

Qualifiers

patients diagnosed with Takayasu arteries with pulmonary arteries involvement

Disqualifiers

Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis

Trial design

Treatments tested in this trial

Percutaneous transluminal pulmonary angioplasty

Treatment groups

No treatment groups listed

Locations

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College100000, Beijing China

Sponsors and collaborators

Chinese Pulmonary Vascular Disease Research Group

Lead sponsor

Source ClinicalTrials.gov